Document and Entity Information
Document and Entity Information | Nov. 09, 2020 |
Document and Entity Information [Abstract] | |
Document Type | 8-K |
Document Period End Date | Nov. 9, 2020 |
Entity File Number | 001-32639 |
Entity Registrant Name | TG Therapeutics, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 36-3898269 |
Entity Address, Address Line One | 2 Gansevoort Street |
Entity Address, Adress Line Two | 9th Floor |
Entity Address, State or Province | NY |
Entity Address, City or Town | New York |
Entity Address, Postal Zip Code | 10014 |
City Area Code | 212 |
Local Phone Number | 554-4484 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock |
Trading Symbol | TGTX |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001001316 |
Amendment Flag | false |